What's happening
This bill requires insurance policies to continue covering single source drugs during formulary changes until appeals or grievances are resolved.
Why it matters
Protects patients from sudden loss of access to essential medications. By requiring continued coverage for single source drugs during formulary changes, patients relying on brand-name drugs without generic alternatives are shielded from abrupt disruptions that could negatively impact their health.
Strengthens patient rights during insurance disputes. The bill ensures patients retain access to their prescribed medication while pursuing an appeal or grievance, reducing the risk that bureaucratic delays or denials could force them to switch medications prematurely.
Limits insurer leverage in formulary negotiations. By obligating insurers to maintain coverage until appeals are resolved, the legislation reduces insurers’ ability to use formulary changes as a pressure tactic, potentially leading to fairer outcomes for consumers.
May impact premium and administrative costs. While the bill enhances patient protections, insurers may face higher costs from covering expensive single source drugs during prolonged appeals, which could eventually be reflected in premiums or insurer practices.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Protect Prescription Drug Coverage
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Relates to coverage for single source drugs
In Senate Committee · Insurance · Sponsor Kevin S. Parker
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4494
2023-2024 Regular Sessions
IN ASSEMBLY
February 16, 2023
Introduced by M. of A. RAMOS -- read once and referred to the Committee on Insurance
AN ACT to amend the insurance law, in relation to coverage for single source drugs
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:
(39) Every individual or blanket policy delivered or issued for delivery in this state providing coverage for prescription drugs through the use of a drug formulary shall include a provision which, in the event of a change to such formulary, allows a covered person who is taking a single source drug covered under such policy that is no longer included in or preferred under such formulary and has filed a grievance or an appeal of the denial of access to the drug with the insurer or a state or federal agency or designee of such agency, to continue receiving coverage for such drug under the same terms and conditions as would apply under the policy were such drug still included in or preferred under the formulary, until a final decision is rendered on the appeal or grievance. For the purpose of this paragraph, "single source drug" means a brandname drug for which there is no generic equivalent.
§ 2. Subsection (k) of section 3221 of the insurance law is amended by adding a new paragraph 23 to read as follows:
(23) Every group or blanket policy delivered or issued for delivery in this state providing coverage for prescription drugs through the use of a drug formulary shall include a provision which, in the event of a change to such formulary, allows a covered person who is taking a single source drug covered under such policy that is no longer included in or preferred under such formulary and has filed a grievance or an appeal of the denial of access to the drug with the insurer or a state or federal agency or designee of such agency, to continue receiving coverage for
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08121-01-3
such drug under the same terms and conditions as would apply under the policy were such drug still included in or preferred under the formulary, until a final decision is rendered on the appeal or grievance. For the purpose of this paragraph, "single source drug" means a brandname drug for which there is no generic equivalent.
§ 3. Section 4303 of the insurance law is amended by adding a new subsection (uu) to read as follows:
(uu) Every contract delivered or issued for delivery in this state providing coverage for prescription drugs through the use of a drug formulary shall include a provision which, in the event of a change to such formulary, allows a covered person who is taking a single source drug covered under such contract that is no longer included in or preferred under such formulary and has filed a grievance or an appeal of the denial of access to the drug with the insurer corporation or organization certified pursuant to article forty-four of the public health law or a state or federal agency or designee of such agency, to continue receiving coverage for such drug under the same terms and conditions as would apply under the contract were such drug still included in or preferred under the formulary, until a final decision is rendered on the appeal or grievance. For the purpose of this subsection, "single source drug" means a brandname drug for which there is no generic equivalent.
§ 4. This act shall take effect on the first of the calendar month next succeeding the sixtieth day after it shall have become a law; provided, however, that this act shall apply only to policies and contracts issued, renewed or amended on or after such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.